Literature DB >> 26940898

Evaluation of the osteogenic potential of Hancornia speciosa latex in rat calvaria and its phytochemical profile.

Juliana Dos Santos Neves1, Marcelo Franchin2, Pedro Luiz Rosalen2, Nadia Fayez Omar3, Mariana Albuquerque Dos Santos3, Jonas Augusto Rizzato Paschoal4, Pedro Duarte Novaes3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: Hancornia speciosa Gomes, commonly known as Mangabeira, is a Brazilian native fruit tree belonging to the Apocynaceae family. In folk medicine, the latex obtained from Mangabeira's trunk has been used as an adjunct therapy for bone fractures. Few pharmacological studies on the Hancornia speciosa latex have been developed and despite its popular use for bone healing there is no data about its biological effect on bone. AIM OF THE STUDY: The present study aimed to investigate the osteogenic potential of Hancornia speciosa latex in rat calvaria, as well as its phytochemical profile.
MATERIALS AND METHODS: A neutral gel composition containing 5% latex was topical applied to a critical size bone defect and over intact calvaria of rats. Areas of newly formed bone on the borders of the defect and of calvaria periosteum were quantified, as well as the percentage of BrdU-positive cells and total cells in the periosteum at different periods of time after latex application. The cytotoxicity of the latex aqueous phase was evaluated in rat calvarial cells in vitro by MTT assay and its phytochemical profile was investigated by ESI-MS/MS.
RESULTS: The area of newly formed bone on the borders of the calvaria defect was larger in rats that received latex at 15 and 30 days of healing. After 3 days of latex application over the intact calvaria, the periosteum area was increased and newly formed bone was observed after 5 and 11 days. There was also an increase in periosteum cell proliferation and population followed latex application on calvaria (p<0.05). The latex aqueous phase limited rat calvarial cell viability in vitro in concentrations larger than 0.6mg/mL. Chlorogenic acid and naringenin-7-O-glucoside were identified in the latex aqueous phase, along with catechin and procyanidin compounds.
CONCLUSION: There was a stimulus for periosteum cell proliferation and bone formation when Hancornia speciosa latex was topically applied on rat calvaria. In addition, chlorogenic acid and naringenin-7-O-glucoside present in Hancornia speciosa latex may contribute to its effects on bone formation.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Bone healing; Hancornia speciosa; Latex; Osteogenic potential; Polyphenols

Mesh:

Substances:

Year:  2016        PMID: 26940898     DOI: 10.1016/j.jep.2016.02.041

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  4 in total

1.  Ontogeny of anastomosed laticifers in the stem apex of Hancornia speciosa (Apocynaceae): a topographic approach.

Authors:  Mayara Pereira Gonçalves; Maria Olívia Mercadante-Simões; Leonardo Monteiro Ribeiro
Journal:  Protoplasma       Date:  2018-05-18       Impact factor: 3.356

2.  Hancornia speciosa Gomes Latex Increases Bone Mineralization in Rats: A Preclinical Study.

Authors:  Francielly Andressa Felipetti; Victor Seabra Lima Prado Costa; Juliana Dos Santos Neves; Ingrid Grazielle Sousa; Sônia Maria De Stefano Piedade; Pedro Duarte Novaes
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2022-01-20

3.  Identification of Phenolic Compounds from Hancornia speciosa (Apocynaceae) Leaves by UHPLC Orbitrap-HRMS.

Authors:  Katherine Xavier Bastos; Clarice Noleto Dias; Yuri Mangueira Nascimento; Marcelo Sobral da Silva; Silvana Maria Zucolotto Langassner; Ludger A Wessjohann; Josean Fechine Tavares
Journal:  Molecules       Date:  2017-01-15       Impact factor: 4.411

4.  Oral Administrations of Hancornia speciosa Gomes Latex Do Not Increase Bone Neoformation.

Authors:  Francielly Andressa Felipetti; Rafaela Mariano Bereta; Sônia Maria Stefano Piedade; Pedro Duarte Novaes
Journal:  Rev Bras Ortop (Sao Paulo)       Date:  2019-09-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.